Phase II Study With Pazopanib and Weekly Paclitaxel in Metastatic or Locally Advanced Squamous Penile Carcinoma Patients Previously Treated With Cisplatin Based Chemotherapy

Trial Profile

Phase II Study With Pazopanib and Weekly Paclitaxel in Metastatic or Locally Advanced Squamous Penile Carcinoma Patients Previously Treated With Cisplatin Based Chemotherapy

Discontinued
Phase of Trial: Phase II

Latest Information Update: 18 Oct 2016

At a glance

  • Drugs Pazopanib (Primary) ; Paclitaxel
  • Indications Penile cancer; Squamous cell cancer
  • Focus Therapeutic Use
  • Acronyms PAZOPEN-SOGUG
  • Most Recent Events

    • 13 Oct 2016 Status changed from recruiting to discontinued.
    • 16 Nov 2015 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
    • 16 Nov 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top